Anti-metastatic potential of human Vδ1+ γδ T cells in an orthotopic mouse xenograft model of colon carcinoma

Cancer Immunology, Immunotherapy

Volumn 62, Issue 7, 2013, Pages 1199-1210

  Devaud, Christel ^a   Rousseau, Benoît ^b   Netzer, Sonia ^a   Pitard, Vincent ^a   Paroissin, Christian ^c   Khairallah, Camille ^a   Costet, Pierre ^b   Moreau, Jean François ^a,d   Couillaud, Franck ^b   Dechanet Merville, Julie ^a   Capone, Myriam ^a  

^a CNRS   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c UNIVERSITÉ DE PAU ET DES PAYS DE L'ADOUR   (France)

^d BORDEAUX UNIVERSITY HOSPITAL   (France)

Author keywords

Bioluminescence imaging; Human T cells; Immunotherapy; Invasive colon carcinoma; Orthotopic mouse xenograft model

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOLUMINESCENCE; CANCER IMMUNOTHERAPY; CANCER INHIBITION; COLON CARCINOMA; COLON METASTASIS; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; GAMMA DELTA T LYMPHOCYTE; HUMAN; HUMAN CELL; IMAGE ANALYSIS; IN VIVO STUDY; METASTASIS INHIBITION; MOLECULAR IMAGING; MOUSE; NONHUMAN; PRIORITY JOURNAL; TREATMENT OUTCOME; TUMOR VOLUME;

ANIMALS; CELL LINE, TUMOR; COLONIC NEOPLASMS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; HUMANS; IMMUNOTHERAPY; MICE; MICE, INBRED NOD; MICE, KNOCKOUT; MICE, SCID; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84879555446     PISSN: 03407004     EISSN: 14320851     Source Type: Journal    
DOI: 10.1007/s00262-013-1402-1     Document Type: Article

References (38)

1. Nguyen DX, Bos PD, Massague J (2009) Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer 9:274-284
2. Pages F, Berger A, Camus M, et al (2005) Effector memory T cells, early metastasis, and survival in colorectal cancer. N Engl J Med 353:2654-2666
3. Galon J, Costes A, Sanchez-Cabo F, et al (2006) Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 313:1960-1964
4. Camus M, Tosolini M, Mlecnik B, et al (2009) Coordination of intratumoral immune reaction and human colorectal cancer recurrence. Cancer Res 69:2685-2693
5. Tosolini M, Kirilovsky A, Mlecnik B, et al (2011) Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, th2, treg, th17) in patients with colorectal cancer. Cancer Res 71:1263-1271
6. Hayday AC (2000) [gamma][delta] cells: a right time and a right place for a conserved third way of protection. Annu Rev Immunol 18:975-1026
7. Hayday AC (2009) Gammadelta T cells and the lymphoid stress-surveillance response. Immunity 31:184-196
8. Hayday A, Theodoridis E, Ramsburg E, et al (2001) Intraepithelial lymphocytes: exploring the third way in immunology. Nat Immunol 2:997-1003
9. Behr C, Capone M, Couzi L, et al (2009) Vdelta2neg gamma-delta T cells, a multi-reactive tissue subset: from innate to adaptive altered-self- surveillance. Open Immunol J 2:106-118
10. Maeurer MJ, Martin D, Walter W, et al (1996) Human intestinal Vdelta1 + lymphocytes recognize tumor cells of epithelial origin. J Exp Med 183:1681-1696
11. Groh V, Steinle A, Bauer S, et al (1998) Recognition of stress-induced MHC molecules by intestinal epithelial gammadelta T cells. Science 279:1737-1740
12. Groh V, Rhinehart R, Secrist H, et al (1999) Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB. Proc Natl Acad Sci USA 96:6879-6884
13. Dechanet J, Merville P, Berge F, et al (1999) Major expansion of gammadelta T lymphocytes following cytomegalovirus infection in kidney allograft recipients. J Infect Dis 179:1-8
14. Dechanet J, Merville P, Lim A, et al (1999) Implication of gammadelta T cells in the human immune response to cytomegalovirus. J Clin Invest 103:1437-1449
15. Pitard V, Roumanes D, Lafarge X, et al (2008) Long-term expansion of effector/memory Vdelta2-gammadelta T cells is a specific blood signature of CMV infection. Blood 112:1317-1324
16. Lafarge X, Merville P, Cazin MC, et al (2001) Cytomegalovirus infection in transplant recipients resolves when circulating gammadelta T lymphocytes expand, suggesting a protective antiviral role. J Infect Dis 184:533-541
17. Halary F, Pitard V, Dlubek D, et al (2005) Shared reactivity of V{delta}2(neg) gamma}{delta} T cells against cytomegalovirus-infected cells and tumor intestinal epithelial cells. J Exp Med 201:1567-1578
18. Devaud C, Bilhere E, Loizon S, et al (2009) Antitumor activity of gammadelta T cells reactive against cytomegalovirus-infected cells in a mouse xenograft tumor model. Cancer Res 69:3971-3978
19. Couzi L, Levaillant Y, Jamai A, et al. (2010) Cytomegalovirus-Induced {gamma}{delta} T Cells Associate with reduced cancer risk after Kidney transplantation. J Am Soc Nephrol 21:181-188
20. Zocchi MR, Poggi A (2004) Role of gammadelta T lymphocytes in tumor defense. Front Biosci 9:2588-2604
21. Kabelitz D, Wesch D, He W (2007) Perspectives of gammadelta T cells in tumor immunology. Cancer Res 67:5-8
22. Shultz LD, Lyons BL, Burzenski LM, et al (2005) Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells. J Immunol 174:6477-6489
23. Geronimi F, Richard E, Redonnet-Vernhet I, et al (2003) Highly efficient lentiviral gene transfer in CD34 + and CD34 +/38-/lin- cells from mobilized peripheral blood after cytokine prestimulation. Stem Cells 21:472-480
24. Davodeau F, Peyrat MA, Hallet MM, et al (1993) Close correlation between Daudi and mycobacterial antigen recognition by human gamma delta T cells and expression of V9JPC1 gamma/V2DJC delta-encoded T cell receptors. J Immunol 151:1214-1223
25. Kataoka T, Shinohara N, Takayama H, et al (1996) Concanamycin A, a powerful tool for characterization and estimation of contribution of perforin- and Fas-based lytic pathways in cell-mediated cytotoxicity. J Immunol 156:3678-3686
26. Giavazzi R, Campbell DE, Jessup JM, et al (1986) Metastatic behavior of tumor cells isolated from primary and metastatic human colorectal carcinomas implanted into different sites in nude mice. Cancer Res 46:1928-1933
27. Price JE, Daniels LM, Campbell DE, et al (1989) Organ distribution of experimental metastases of a human colorectal carcinoma injected in nude mice. Clin Exp Metastasis 7:55-68
28. Garofalo A, Chirivi RG, Scanziani E, et al (1993) Comparative study on the metastatic behavior of human tumors in nude, beige/nude/xid and severe combined immunodeficient mice. Invasion Metastasis 13:82-91
29. Girardi M, Oppenheim DE, Steele CR, et al (2001) Regulation of cutaneous malignancy by gammadelta T cells. Science 294:605-609
30. Matsuda S, Kudoh S, Katayama S (2001) Enhanced formation of azoxymethane-induced colorectal adenocarcinoma in gammadelta T lymphocyte-deficient mice. Jpn J Cancer Res 92:880-885
31. Ma C, Zhang Q, Ye J, et al. (2012) Tumor-Infiltrating gammadelta T lymphocytes predict clinical outcome in human breast cancer. J Immunol 189:5029-5036
32. Fidler IJ (1990) Critical factors in the biology of human cancer metastasis: twenty-eighth G.H.A. Clowes memorial award lecture. Cancer Res 50:6130-6138
33. Joyce JA, Pollard JW (2009) Microenvironmental regulation of metastasis. Nat Rev Cancer 9:239-252
34. Yuasa T, Sato K, Ashihara E, et al (2009) Intravesical administration of gammadelta T cells successfully prevents the growth of bladder cancer in the murine model. Cancer Immunol Immunother 58:493-502
35. Bryant NL, Gillespie GY, Lopez RD, et al (2011) Preclinical evaluation of ex vivo expanded/activated gammadelta T cells for immunotherapy of glioblastoma multiforme. J Neurooncol 101:179-188
36. Jojovic M, Schumacher U (2000) Quantitative assessment of spontaneous lung metastases of human HT29 colon cancer cells transplanted into SCID mice. Cancer Lett 152:151-156
37. Elmaagacli AH, Steckel NK, Koldehoff M, et al (2011) Early human cytomegalovirus replication after transplantation is associated with a decreased relapse risk: evidence for a putative virus-versus-leukemia effect in acute myeloid leukemia patients. Blood 118:1402-1412
38. Lamb LS Jr, Musk P, Ye Z, et al (2001) Human gammadelta(+) T lymphocytes have in vitro graft vs leukemia activity in the absence of an allogeneic response. Bone Marrow Transpl 27:601-606